[Lung cancer in Eastern Morocco: where do we stand?]

Pan Afr Med J. 2019;34:177

Authors: Belmokhtar KY, Tajir M, Boulouiz R, Bennani A, Brahmi SA, Alloubi I, Kouismi H, Kamaoui I, Skiker I, Afqir S, Abda N, Bellaoui M, Mezouar L

Abstract
Introduction: Lung cancer is the most common cancer in men living Eastern Morocco. We here present the first report on the clinical, pathological and therapeutic features of lung cancer in Eastern Morocco.
Methods: We conducted a retrospective study of 738 patients diagnosed with lung cancer at the Hassan II, Oncology Center between October 2005 and December 2014.
Results: Among the cases studied, 671 patients were men and 67 women; 95.01% of men and 1.54% of women were smokers. The average age of patients was 59.1 ± 11.9 years. Most patients (97%) were diagnosed at advanced stage disease. Only 4 out of 227 patients with advanced adenocarcinoma underwent molecular test. In addition, no patient in our series received targeted therapy. In this series, 20.46% of patients had less than 50 years. Compared to patients aged 50 years and older, cannabis consumption was higher (p<0.001) in patients less than 50 years and as well as a higher rate of adenocarcinoma (p<0.01). By contrast, in these patients, tobacco consumption was lower (p<0.001) as well as the rate of squamous cell carcinoma (p<0.01) and small cell cancer (p<0.05).
Conclusion: Unlike Western countries, in Eastern Morocco lung cancer is diagnosed late, affects younger people and access to molecular tests is still very limited. These results justify the need to implement effective programs against lung cancer as well as to facilitate access to molecular tests and new therapeutic tools in Eastern Morocco.

PMID: 32153717 [PubMed – in process]


Source: ncbi 2

Partage le savoir
Categories: Medical

error: Content is protected !!